RELN and atherosclerosis: Moreover, inhibition of AT2R by PD123319 co-treatment activated two IPA-predicted signaling pathways that contribute to cell death (Cell death of muscle cells pathway: Figure 7A) and vascular damage (Reelin signaling pathway that promotes atherosclerosis).